Literature DB >> 3720194

Pressor effect of arginine vasopressin in progressive autonomic failure.

T D Williams, D Da Costa, C J Mathias, R Bannister, S L Lightman.   

Abstract

The blood pressure (BP) and heart rate (HR) responses to 5 min incremental intravenous infusions of noradrenaline (NA) and arginine vasopressin (AVP) were investigated both in patients with progressive autonomic failure (PAF) and in normal volunteers. Stepwise infusion of NA at rates of 300-3000 pmol min-1 kg-1 produced a bradycardia and a dose related increase in BP in normal subjects. In subjects with PAF there was no significant HR response but the dose-BP response was shifted to the left with significant pressor responses at infusion rates of 60-300 pmol min-1 kg-1. Stepwise infusion of AVP at 0.2-5.0 pmol min-1 kg-1 caused transient bradycardia but no pressor response in seven normal volunteers. Further increases in AVP infusion in three other subjects achieved plasma AVP levels as high as 3000-4000 pmol/l, and still no significant pressor response was observed. Stepwise infusion of AVP at 0.05-2.0 pmol min-1 kg-1 in the eight subjects with PAF resulted in a pressor response without any change in HR. During this infusion plasma AVP increased from 0.8 +/- 0.2 (mean +/- SEM) to 30 +/- 2 pmol/l. A significant pressor response was already apparent at a plasma AVP level of 5.5 +/- 1.8 pmol/l.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3720194     DOI: 10.1042/cs0710173

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

1.  Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial.

Authors:  Carrie A Sims; Daniel Holena; Patrick Kim; Jose Pascual; Brian Smith; Neils Martin; Mark Seamon; Adam Shiroff; Shariq Raza; Lewis Kaplan; Elena Grill; Nicole Zimmerman; Christopher Mason; Benjamin Abella; Patrick Reilly
Journal:  JAMA Surg       Date:  2019-11-01       Impact factor: 14.766

2.  Differences in overshoot of blood pressure after head-up tilt in two groups with chronic autonomic failure: pure autonomic failure and multiple system atrophy.

Authors:  Masato Asahina; Tim M Young; Katharine Bleasdale-Barr; Christopher J Mathias
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

3.  Effects of arginine-vasopressin on regional blood volume distribution in supine humans.

Authors:  H B Hopf; K D Stühmeier; W Klement; K J Langen; J Peters
Journal:  Basic Res Cardiol       Date:  1993 May-Jun       Impact factor: 17.165

4.  Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.

Authors:  R G Wilcox; T Bennett; I A Macdonald; F Broughton Pipkin; P H Baylis
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

Review 5.  Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.

Authors:  Matthias Lange; Christian Ertmer; Martin Westphal
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

6.  Ischemic electrocardiographic change induced by exercise in a patient with chronic autonomic failure.

Authors:  Masato Asahina; Akiyuki Hiraga; Yuhoko Hayashi; Keiko Mizobuchi; Ryuji Sakakibara; Kwangho Lee; Takamichi Hattori
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

7.  Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?

Authors:  Irene Gavras; Haralambos Gavras
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

Review 8.  Role of vasopressin in current anesthetic practice.

Authors:  Keun Suk Park; Kyung Yeon Yoo
Journal:  Korean J Anesthesiol       Date:  2017-05-26

9.  Arginine vasopressin--a mediator of chemotherapy induced emesis?

Authors:  C M Edwards; J Carmichael; P H Baylis; A L Harris
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

10.  Exogenous vasopressin dose-dependently modulates gastric microcirculatory oxygenation in dogs via V1A receptor.

Authors:  Richard Truse; Steven Grewe; Anna Herminghaus; Jan Schulz; Andreas P M Weber; Tabea Mettler-Altmann; Inge Bauer; Olaf Picker; Christian Vollmer
Journal:  Crit Care       Date:  2019-11-12       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.